Title : BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression.

Pub. Date : 2021 Oct 1

PMID : 34301753






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BCMA-specific ADC MEDI2228 and Daratumumab induce synergistic myeloma cytotoxicity via IFN-driven immune responses and enhanced CD38 expression. medi2228 interferon alpha 1 Homo sapiens